Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shigetaka Kitajima is active.

Publication


Featured researches published by Shigetaka Kitajima.


Journal of Biological Chemistry | 2001

Homocysteine Induces Programmed Cell Death in Human Vascular Endothelial Cells through Activation of the Unfolded Protein Response

Chun Zhang; Yong Cai; Mimi T. Adachi; Satoru Oshiro; Teijiro Aso; Randal J. Kaufman; Shigetaka Kitajima

Severe hyperhomocysteinemia is associated with endothelial cell injury that may contribute to an increased incidence of thromboembolic disease. In this study, homocysteine induced programmed cell death in human umbilical vein endothelial cells as measured by TdT-mediated dUTP nick end labeling assay, DNA ladder formation, induction of caspase 3-like activity, and cleavage of procaspase 3. Homocysteine-induced cell death was specific to homocysteine, was not mediated by oxidative stress, and was mimicked by inducers of the unfolded protein response (UPR), a signal transduction pathway activated by the accumulation of unfolded proteins in the lumen of the endoplasmic reticulum. Dominant negative forms of the endoplasmic reticulum-resident protein kinases IRE1α and -β, which function as signal transducers of the UPR, prevented the activation of glucose-regulated protein 78/immunoglobulin chain-binding protein and C/EBP homologous protein/growth arrest and DNA damage-inducible protein 153 in response to homocysteine. Furthermore, overexpression of the point mutants of IRE1 with defective RNase more effectively suppressed the cell death than the kinase-defective mutant. These results indicate that homocysteine induces apoptosis in human umbilical vein endothelial cells by activation of the UPR and is signaled through IRE1. The studies implicate that the UPR may cause endothelial cell injury associated with severe hyperhomocysteinemia.


Journal of Biological Chemistry | 1998

Cloning and Characterization of the Hakata Antigen, a Member of the Ficolin/Opsonin p35 Lectin Family

Rie Sugimoto; Yoshiaki Yae; Mina Akaiwa; Shigetaka Kitajima; Yosaburo Shibata; Hiroyuki Sato; Joji Hirata; Kazuo Okochi; Kenji Izuhara; Naotaka Hamasaki

The Hakata antigen is a novel, thermolabile β2-macroglycoprotein that reacts with sera from patients suffering from systemic lupus erythematosus. In this study we present the structure and the function of the Hakata antigen. We have identified cDNA clones encoding the Hakata antigen and analyzed its function. The cDNA included a possible open reading frame of 897 nucleotides, encoding 299 amino acids. The Hakata antigen consisted of a collagen-like domain in the middle section and a fibrinogen-like domain in the COOH terminus, both of which are homologous to human ficolin-1 and opsonin P35, indicating that these three molecules form a distinct family. The molecular mass of the Hakata antigen expressed in transfected cells was 35 kDa under reduced conditions, and it formed ladder bands under nonreducing conditions compatible with the previous result that the Hakata antigen exists in serum as homopolymers. Purified Hakata antigen sustained lectin activity, showing affinity with GalNAc, GlcNAc, d-fucose as mono/oligosaccharide, and lipopolysaccharides from Salmonella typhimurium andSalmonella minnesota. These results suggest that the Hakata antigen, a new member of the ficolin/opsonin P35 family, plays a role in the serum exerting lectin activity under physiological conditions.


Journal of Biological Chemistry | 1997

p32 Protein, a Splicing Factor 2-associated Protein, Is Localized in Mitochondrial Matrix and Is Functionally Important in Maintaining Oxidative Phosphorylation

Tsuyoshi Muta; Dongchon Kang; Shigetaka Kitajima; Toshiyuki Fujiwara; Naotaka Hamasaki

Human p32, originally cloned as a splicing factor 2-associated protein, has been reported to interact with a variety of molecules including human immunodeficiency virus Tat and complement 1q (C1q). p32 protein is supposed to be in the nucleus and on the plasma membrane for the association with human immunodeficiency virus Tat and C1q, respectively. None of the interactions, however, is proven to have a physiological role. To investigate the physiological function of p32, we determined the intracellular localization of p32. The fractionation of cells, fluorescent immunocytochemistry, and electron microscopic immunostaining show that p32 is exclusively localized in the mitochondrial matrix. We cloned a Saccharomyces cerevisiaehomologue of human p32 gene, referred to yeast p30 gene. The yeast p30 protein is also localized in the mitochondrial matrix. The disruption of the p30 gene caused the growth retardation of yeast cells in a glycerol medium but not in a glucose medium, i.e. the impairment of the mitochondrial ATP synthesis. The growth impairment was restored by the introduction of the human p32 cDNA, indicating that p30 is a functional yeast counterpart of human p32. Taken together, both p32 and p30 reside in mitochondrial matrix and play an important role in maintaining mitochondrial oxidative phosphorylation.


Circulation Research | 2003

Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation.

Mimi Tamamori-Adachi; Hiroshi Ito; Piyamas Sumrejkanchanakij; Susumu Adachi; Michiaki Hiroe; Masato Shimizu; Junya Kawauchi; Makoto Sunamori; Fumiaki Marumo; Shigetaka Kitajima; Masa-Aki Ikeda

Abstract— Mammalian cardiomyocytes irreversibly lose their capacity to proliferate soon after birth, yet the underlying mechanisms have been unclear. Cyclin D1 and its partner, cyclin-dependent kinase 4 (CDK4), are important for promoting the G1-to-S phase progression via phosphorylation of the retinoblastoma (Rb) protein. Mitogenic stimulation induces hypertrophic cell growth and upregulates expression of cyclin D1 in postmitotic cardiomyocytes. In the present study, we show that, in neonatal rat cardiomyocytes, D-type cyclins and CDK4 were predominantly cytoplasmic, whereas Rb remained in an underphosphorylated state. Ectopically expressed cyclin D1 localized in the nucleus of fetal but not neonatal cardiomyocytes. To target cyclin D1 to the nucleus efficiently, we constructed a variant of cyclin D1 (D1NLS), which directly linked to nuclear localization signals (NLSs). Coinfection of recombinant adenoviruses expressing D1NLS and CDK4 induced Rb phosphorylation and CDK2 kinase activity. Furthermore, D1NLS/CDK4 was sufficient to promote the reentry into the cell cycle, leading to cell division. The number of cardiomyocytes coinfected with these viruses increased 3-fold 5 days after infection. Finally, D1NLS/CDK4 promoted cell cycle reentry of cardiomyocytes in adult hearts injected with these viruses, evaluated by the expression of Ki-67, which is expressed in proliferating cells in all phases of the cell cycle, and BrdU incorporation. Thus, postmitotic cardiomyocytes have the potential to proliferate provided that cyclin D1/CDK4 accumulate in the nucleus, and the prevention of their nuclear import plays a critical role as a physical barrier to prevent cardiomyocyte proliferation. Our results provide new insights into the development of therapeutics strategies to induce regeneration of cardiomyocytes. The full text of this article is available at http://www.circresaha.org.


Proceedings of the National Academy of Sciences of the United States of America | 2008

Distinct roles of GSK-3α and GSK-3β phosphorylation in the heart under pressure overload

Takahisa Matsuda; Peiyong Zhai; Yasuhiro Maejima; Chull Hong; Shumin Gao; Bin Tian; Kazumichi Goto; Hiromitsu Takagi; Mimi Tamamori-Adachi; Shigetaka Kitajima; Junichi Sadoshima

Glycogen synthase kinase-3 (GSK-3) is a master regulator of growth and death in cardiac myocytes. GSK-3 is inactivated by hypertrophic stimuli through phosphorylation-dependent and -independent mechanisms. Inactivation of GSK-3 removes the negative constraint of GSK-3 on hypertrophy, thereby stimulating cardiac hypertrophy. N-terminal phosphorylation of the GSK-3 isoforms GSK-3α and GSK-3β by upstream kinases (e.g., Akt) is a major mechanism of GSK-3 inhibition. Nonetheless, its role in mediating cardiac hypertrophy and failure remains to be established. Here we evaluated the role of Serine(S)21 and S9 phosphorylation of GSK-3α and GSK-3β in the regulation of cardiac hypertrophy and function during pressure overload (PO), using GSK-3α S21A knock-in (αKI) and GSK-3β S9A knock-in (βKI) mice. Although inhibition of S9 phosphorylation during PO in the βKI mice attenuated hypertrophy and heart failure (HF), inhibition of S21 phosphorylation in the αKI mice unexpectedly promoted hypertrophy and HF. Inhibition of S21 phosphorylation in GSK-3α, but not of S9 phosphorylation in GSK-3β, caused phosphorylation and down-regulation of G1-cyclins, due to preferential localization of GSK-3α in the nucleus, and suppressed E2F and markers of cell proliferation, including phosphorylated histone H3, under PO, thereby contributing to decreases in the total number of myocytes in the heart. Restoration of the E2F activity by injection of adenovirus harboring cyclin D1 with a nuclear localization signal attenuated HF under PO in the αKI mice. Collectively, our results reveal that whereas S9 phosphorylation of GSK-3β mediates pathological hypertrophy, S21 phosphorylation of GSK-3α plays a compensatory role during PO, in part by alleviating the negative constraint on the cell cycle machinery in cardiac myocytes.


The EMBO Journal | 2005

Stress response gene ATF3 is a target of c-myc in serum-induced cell proliferation.

Kiyoshi Tamura; Bayin Hua; Susumu Adachi; Isil Guney; Junya Kawauchi; Masaki Suimye Morioka; Mimi Tamamori-Adachi; Yujiro Tanaka; Yusaku Nakabeppu; Makoto Sunamori; John M. Sedivy; Shigetaka Kitajima

The c‐myc proto‐oncogene encodes a transcription factor that promotes cell cycle progression and cell proliferation, and its deficiency results in severely retarded proliferation rates. The ATF3 stress response gene encodes a transcription factor that plays a role in determining cell fate under stress conditions. Its biological significance in the control of cell proliferation and its crosstalk regulation, however, are not well understood. Here, we report that the serum response of the ATF3 gene expression depends on c‐myc gene and that the c‐Myc complex at ATF/CREB site of the gene promoter plays a role in mediating the serum response. Intriguingly, ectopic expression of ATF3 promotes proliferation of c‐myc‐deficient cells, mostly by alleviating the impeded G1‐phase progression observed in these cells, whereas ATF3 knockdown significantly suppresses proliferation of wild‐type cells. Our study demonstrates that ATF3 is downstream of the c‐Myc signaling pathway and plays a role in mediating the cell proliferation function of c‐Myc. Our results provide a novel insight into the functional link of the stress response gene ATF3 and the proto‐oncogene c‐myc.


Journal of Biological Chemistry | 2002

Cell-cycle-dependent regulation of human aurora A transcription is mediated by periodic repression of E4TF1.

Masatsugu Tanaka; Atsuhisa Ueda; Heiwa Kanamori; Haruko Ideguchi; Jun Yang; Shigetaka Kitajima; Yoshiaki Ishigatsubo

Human aurora A is a serine-threonine kinase that controls various mitotic events. The transcription of aurora A mRNA varies throughout the cell cycle and peaks during G2/M. To clarify the transcriptional mechanism, we first cloned the 1.8-kb 5′-flanking region of aurora A including the first exon. Transient expression of aurora Apromoter-luciferase constructs containing a series of 5′-truncated sequences or site-directed mutations identified a 7-bp sequence (CTTCCGG) from −85 to −79 as a positive regulatory element. Electromobility shift assays identified the binding of positive regulatory proteins to the CTTCCGG element. Anti-E4TF1–60 antibody generated a supershifted complex. Furthermore, coexpression of E4TF1–60 and E4TF1–53 markedly increased aurora Apromoter activity. Synchronized cells transfected with the aurora A promoter-luciferase constructs revealed that the promoter activity of aurora A increased in the S phase and peaked at G2/M. In addition, we identified a tandem repressor element, CDE/CHR, just downstream of the CTTCCGG element, and mutation within this element led to a loss of cell cycle regulation. We conclude that the transcription of aurora A is positively regulated by E4TF1, a ubiquitously expressed ETS family protein, and that the CDE/CHR element was essential for the G2/M-specific transcription of aurora A.


Circulation Research | 2009

Activating Transcription Factor 3 Constitutes a Negative Feedback Mechanism That Attenuates Saturated Fatty Acid/Toll-Like Receptor 4 Signaling and Macrophage Activation in Obese Adipose Tissue

Takayoshi Suganami; Xunmei Yuan; Yuri Shimoda; Kozue Uchio-Yamada; Nobutaka Nakagawa; Ibuki Shirakawa; Takako Usami; Takamitsu Tsukahara; Keizo Nakayama; Yoshihiro Miyamoto; Kazuki Yasuda; Junichiro Matsuda; Yasutomi Kamei; Shigetaka Kitajima; Yoshihiro Ogawa

Obese adipose tissue is markedly infiltrated by macrophages, suggesting that they may participate in the inflammatory pathways that are activated in obese adipose tissue. Evidence has suggested that saturated fatty acids released via adipocyte lipolysis serve as a naturally occurring ligand that stimulates Toll-like receptor (TLR)4 signaling, thereby inducing the inflammatory responses in macrophages in obese adipose tissue. Through a combination of cDNA microarray analyses of saturated fatty acid–stimulated macrophages in vitro and obese adipose tissue in vivo, here we identified activating transcription factor (ATF)3, a member of the ATF/cAMP response element-binding protein family of basic leucine zipper-type transcription factors, as a target gene of saturated fatty acids/TLR4 signaling in macrophages in obese adipose tissue. Importantly, ATF3, when induced by saturated fatty acids, can transcriptionally repress tumor necrosis factor-α production in macrophages in vitro. Chromatin immunoprecipitation assay revealed that ATF3 is recruited to the region containing the activator protein-1 site of the endogenous tumor necrosis factor-α promoter. Furthermore, transgenic overexpression of ATF3 specifically in macrophages results in the marked attenuation of proinflammatory M1 macrophage activation in the adipose tissue from genetically obese KKAy mice fed high-fat diet. This study provides evidence that ATF3, which is induced in obese adipose tissue, acts as a transcriptional repressor of saturated fatty acids/TLR4 signaling, thereby revealing the negative feedback mechanism that attenuates obesity-induced macrophage activation. Our data also suggest that activation of ATF3 in macrophages offers a novel therapeutic strategy to prevent or treat obesity-induced adipose tissue inflammation.


Journal of Clinical Investigation | 2008

Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma

Sin-Ae Lee; Sung-Yul Lee; Ik-Hyun Cho; Min-A Oh; Eun-Sil Kang; Yong-Bae Kim; Woo Duck Seo; Suyong Choi; Ju-Ock Nam; Mimi Tamamori-Adachi; Shigetaka Kitajima; Sang-Kyu Ye; Semi Kim; Yoon-Jin Hwang; In-San Kim; Ki Hun Park; Jung Weon Lee

The growth of normal cells is arrested when they come in contact with each other, a process known as contact inhibition. Contact inhibition is lost during tumorigenesis, resulting in uncontrolled cell growth. Here, we investigated the role of the tetraspanin transmembrane 4 superfamily member 5 (TM4SF5) in contact inhibition and tumorigenesis. We found that TM4SF5 was overexpressed in human hepatocarcinoma tissue. TM4SF5 expression in clinical samples and in human hepatocellular carcinoma cell lines correlated with enhanced p27Kip1 expression and cytosolic stabilization as well as morphological elongation mediated by RhoA inactivation. These TM4SF5-mediated effects resulted in epithelial-mesenchymal transition (EMT) via loss of E-cadherin expression. The consequence of this was aberrant cell growth, as assessed by S-phase transition in confluent conditions, anchorage-independent growth, and tumor formation in nude mice. The TM4SF5-mediated effects were abolished by suppressing the expression of either TM4SF5 or cytosolic p27Kip1, as well as by reconstituting the expression of E-cadherin. Our observations have revealed a role for TM4SF5 in causing uncontrolled growth of human hepatocarcinoma cells through EMT.


Biochemical and Biophysical Research Communications | 2002

Transcriptional activation of the human stress-inducible transcriptional repressor ATF3 gene promoter by p53.

Chun Zhang; Choungfeng Gao; Junya Kawauchi; Yoshinori Hashimoto; Nobuo Tsuchida; Shigetaka Kitajima

Activating transcription factor 3 (ATF3) is an immediate early response gene that is induced in cells exposed to a variety of stress stimuli. In this report, upon exposure of cells to ultraviolet (UV) or proteasome inhibitor MG132, ATF3 protein was induced more efficiently in cells with intact p53 allele than in those with null mutant p53 allele. In Saos-2 cells harboring the temperature-sensitive mutant p53(Val-138), the expression of ATF3 gene was more significant at permissive temperature of 32.5 degrees C than at non-permissive 37.5 degrees C. Reporter assay of the human ATF3 gene promoter identified two p53-responsive elements at -379 to -370 and -351 to -342 from the transcriptional start site. These elements were capable of conferring p53 responsiveness to a heterologous promoter and specifically bound p53 protein in electrophoretic mobility shift assay. Furthermore, ATF3 gene promoter was more significantly activated by UV in cells with wild p53 allele. These results clearly show that the human ATF3 gene is one of the target genes directly activated by p53 and may suggest a functional link between stress-inducible transcriptional repressor ATF3 and p53.

Collaboration


Dive into the Shigetaka Kitajima's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Junya Kawauchi

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Teijiro Aso

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Yukio Yasukochi

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Satoru Oshiro

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Chun Zhang

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Yujiro Tanaka

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Susumu Adachi

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge